Ipratropium Bromide
CAS number： 22254-24-6
Molecular formula： C20H30BrNO3
molecular weight： 412.36
Chemical structure：
Producers shown on SFDA
(Record date:18/10/2021）
Producer | Documents | GMP Valid till(based on SFDA) |
Jewim Pharmaceutical (Shandong) Co., Ltd. | GMP | Valid till January 2022 |
CR Double-Crane Pharmaceutical Co.,Ltd. | GMP | Valid till August 2021 |
Producers shown on EP
(Quoted from EP website；record date:18/10/2021）
| Substance | Certificate Holder | Certificate Number | Issue Date | Status | End date | Type |
| Ipratropium bromide | Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Am Rhein DE | R1-CEP 1996-005 - Rev 05 | 08/10/2015 | Valid | / | Chemical |
| Ipratropium bromide | CIPLA LIMITED Mumbai IN | R0-CEP 2015-340 - Rev 00 | 16/12/2016 | Valid | / | Chemical |
| Ipratropium bromide | AARTI INDUSTRIES LIMITED Mulund (W), Mumbai IN | R1-CEP 2008-150 - Rev 01 | 14/02/2017 | Valid | / | Chemical |
| Ipratropium bromide | MELODY HEALTHCARE PVT. LTD. Boisar IN | R0-CEP 2017-302 - Rev 01 | 19/06/2020 | Valid | / | Chemical |
| Ipratropium bromide | Lusochimica S.p.A. Lomagna IT | R1-CEP 2004-220 - Rev 01 | 26/11/2020 | Valid | / | Chemical |
| Ipratropium bromide | OLON S.P.A. Rodano IT | R1-CEP 1998-083 - Rev 08 | 28/06/2021 | Valid | / | Chemical |
| Ipratropium bromide | NEULAND LABORATORIES LIMITED Hyderabad IN | R1-CEP 2012-126 - Rev 01 | 07/09/2021 | Valid | / | Chemical |
Producer:Jewim Pharmaceutical (Shandong) Co., Ltd. is located in an area of 200 mu, All the dosage forms of the company's listed products have passed the inspection and certification of the China food and drug administration, and the quality system has repeatedly passed the GMP certification of the Australian drug administration (TGA). The products are exported to more than 50 countries such as the United States, Australia and New Zealand.
Staff size:900-999 persons
Registered capital:RMB 100 million
Producer: CR Double-Crane Pharmaceutical Co.,Ltd.was established in 1939.
The company currently has 21 subsidiaries and more than 11000 employees. Its main business includes new drug R & D, preparation production, drug sales, pharmaceutical equipment and API production. It has rich product lines, high-quality product quality, strong channel and terminal coverage and management ability, good brand advantages and international advantages, profound corporate culture and dynamic talent team, economic strength, competitive vitality and sustainable development ability, and ranks in the forefront of domestic pharmaceutical enterprises.
Staff size:11000-11999 persons
Registered capital:RMB 1 billion 43 million
For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978
Tel: Cell/WhatsApp/WeChat: +86 18402846978
Email: paulzhang@yinuopharmchem.com
SKYPE